Literature DB >> 1934592

Lactate dehydrogenase (LDH) isoenzymes and proliferative activity of lymphoid cells--an immunocytochemical study.

L Pan1, P C Beverley, P G Isaacson.   

Abstract

In a recent immunohistochemical study, we suggested that elevation of LDH isoenzymes is generally related to cell proliferation. To explore this relationship further, we have now examined the expression of H- and M-type LDH isoenzymes immunocytochemically in human resting and mitogen-activated B and T lymphocytes. In the resting state, T lymphocytes showed strong staining for H-type LDH but showed little or no staining for M-type LDH, while B lymphocytes showed only weak staining for M-type LDH. During activation of T cells, M-type LDH started to increase when cells entered the early stages of the cell cycle. The staining intensity increased to a maximum when the percentage of the T cells at the S/G2/M phases of the cell cycle reached its peak. M-type LDH expression declined when the activated T cells returned to their resting state. Staining for H-type LDH remained strong in T cells during activation. In B lymphocytes, both H- and M-type LDH isoenzymes increased concomitantly following activation and the staining intensity also correlated well with the percentage of the S/G2/M fraction. The expression of H- and M-type LDH was also determined in fresh leukaemia and a variety of lymphoid cell lines. It was noted that cells of chronic lymphocytic leukaemia (CLL) and pro-lymphocytic leukaemia (PLL), morphologically similar to normal lymphocytes, showed a LDH staining pattern resembling that of resting B lymphocytes, while lymphoblasts in T cell acute lymphoblastic leukaemia (T-ALL), high grade B cell lymphoma and Epstein-Barr virus (EBV) transformed cell lines showed a LDH staining pattern similar to that in activated T or B lymphocytes. Taken together, our results have demonstrated a significant correlation between expression of LDH and proliferative activity of cells. Immunostaining with the MoAbs to H- and M-type LDH can, therefore, provide a useful means not only for identification of T and B lymphocytes but also for rapid evaluation of the proliferating fraction of normal and neoplastic human cell populations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1934592      PMCID: PMC1554126          DOI: 10.1111/j.1365-2249.1991.tb05803.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Production of monoclonal antibodies to lactate dehydrogenase (LDH) isoenzymes for immunohistochemical study on fixed tissue section.

Authors:  L X Pan; P C Beverley; L G Bobrow; D M Swallow; P G Isaacson
Journal:  Histochem J       Date:  1989-11

2.  Monoclonal antibody to cytokeratin for use in routine histopathology.

Authors:  C A Makin; L G Bobrow; W F Bodmer
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

3.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

4.  Elevation of serum lactic dehydrogenase levels as an early marker of occult malignant lymphoma.

Authors:  Z Rotenberg; I Weinberger; Y Fuchs; A Erdberg; E Davidson; J Agmon
Journal:  Cancer       Date:  1984-10-01       Impact factor: 6.860

5.  Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.

Authors:  S Romagnani; M G Giudizi; R Biagiotti; F Almerigogna; E Maggi; G Del Prete; M Ricci
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

6.  Creatine kinase and lactate dehydrogenase isoenzymes in serum and tissues of patients with stomach adenocarcinoma.

Authors:  R D Hirata; M H Hirata; B Strufaldi; R A Possik; M Asai
Journal:  Clin Chem       Date:  1989-07       Impact factor: 8.327

7.  Lactate dehydrogenase isoenzymes in human malignant tumors.

Authors:  B Hrabac; D Catović; A Nikulin
Journal:  Neoplasma       Date:  1984       Impact factor: 2.575

8.  Lactic dehydrogenase in the monitoring and prognosis of testicular cancer.

Authors:  M C Lippert; N Javadpour
Journal:  Cancer       Date:  1981-11-15       Impact factor: 6.860

9.  Prognostic value of serum lactic dehydrogenase in non-Hodgkin's lymphoma.

Authors:  H Hagberg; A Siegbahn
Journal:  Scand J Haematol       Date:  1983-07

10.  Elevated lactate dehydrogenase isoenzyme 1 as a tumour marker in patients with germ cell testicular tumours.

Authors:  D C Winkle; A E Clague; R A Gardiner
Journal:  Aust N Z J Surg       Date:  1988-09
View more
  12 in total

Review 1.  Investigation of NK cell function and their modulation in different malignancies.

Authors:  Gordana Konjevic; Vladimir Jurisic; Viktor Jovic; Ana Vuletic; Katarina Mirjacic Martinovic; Sandra Radenkovic; Ivan Spuzic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

Review 2.  Oncogenes in tumor metabolism, tumorigenesis, and apoptosis.

Authors:  C V Dang; B C Lewis; C Dolde; G Dang; H Shim
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

3.  Prognostic significance of biochemical markers in African Burkitt's lymphoma.

Authors:  F K N Arthur; L Owusu; F A Yeboah; T Rettig; A Osei-Akoto
Journal:  Clin Transl Oncol       Date:  2011-10       Impact factor: 3.405

4.  The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.

Authors:  Alexandre V Hirayama; Jordan Gauthier; Kevin A Hay; Jenna M Voutsinas; Qian Wu; Ted Gooley; Daniel Li; Sindhu Cherian; Xueyan Chen; Barbara S Pender; Reed M Hawkins; Aesha Vakil; Rachel N Steinmetz; Utkarsh H Acharya; Ryan D Cassaday; Aude G Chapuis; Tejaswini M Dhawale; Paul C Hendrie; Hans-Peter Kiem; Ryan C Lynch; Jorge Ramos; Mazyar Shadman; Brian G Till; Stanley R Riddell; David G Maloney; Cameron J Turtle
Journal:  Blood       Date:  2019-02-19       Impact factor: 22.113

5.  Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy.

Authors:  Kevin A Hay; Jordan Gauthier; Alexandre V Hirayama; Jenna M Voutsinas; Qian Wu; Daniel Li; Ted A Gooley; Sindhu Cherian; Xueyan Chen; Barbara S Pender; Reed M Hawkins; Aesha Vakil; Rachel N Steinmetz; Gary Schoch; Aude G Chapuis; Brian G Till; Hans-Peter Kiem; Jorge D Ramos; Mazyar Shadman; Ryan D Cassaday; Utkarsh H Acharya; Stanley R Riddell; David G Maloney; Cameron J Turtle
Journal:  Blood       Date:  2019-02-06       Impact factor: 22.113

6.  Regulated, stable expression and nuclear presence of reovirus double-stranded RNA-binding protein sigma3 in HeLa cells.

Authors:  Z Yue; A J Shatkin
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study.

Authors:  Yi Han; Haidong Zhang; Sucheng Mu; Wei Wei; Chaoyuan Jin; Chaoyang Tong; Zhenju Song; Yunfei Zha; Yuan Xue; Guorong Gu
Journal:  Aging (Albany NY)       Date:  2020-06-24       Impact factor: 5.682

8.  Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia.

Authors:  Furun An; Huiping Wang; Zhenyun Liu; Fan Wu; Jiakui Zhang; Qianshan Tao; Yingwei Li; Yuanyuan Shen; Yanjie Ruan; Qing Zhang; Ying Pan; Weiwei Zhu; Hui Qin; Yansheng Wang; Yongling Fu; Zhenqing Feng; Zhimin Zhai
Journal:  Nat Commun       Date:  2020-11-23       Impact factor: 14.919

9.  Influence of lactate dehydrogenase and cyclosporine A level on the incidence of acute graft-versus-host disease after allogeneic stem cell transplantation.

Authors:  Moo-Kon Song; Joo-Seop Chung; Young-Mi Seol; Bo-Ran Kwon; Ho-Jin Shin; Young-Jin Choi; Goon-Jae Cho
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153

10.  Infection with Mycobacterium tuberculosis induces the Warburg effect in mouse lungs.

Authors:  Lanbo Shi; Hugh Salamon; Eliseo A Eugenin; Richard Pine; Andrea Cooper; Maria L Gennaro
Journal:  Sci Rep       Date:  2015-12-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.